Referências
Principais artigos
Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39.Texto completo Resumo
Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739. Resumo
Artigos de referência
1. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-39.Texto completo Resumo
2. Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85.Texto completo Resumo
3. Gwaltney JM Jr, Hendley JO, Simon G, et al. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA. 1967 Nov 6;202(6):494-500. Resumo
4. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. 2004 May;193:3-5. Resumo
5. Osguthorpe JD. Adult rhinosinusitis: diagnosis and management. Am Fam Physician. 2001 Jan 1;63(1):69-77.Texto completo Resumo
6. Piccirillo JF. Clinical practice. Acute bacterial sinusitis. N Engl J Med. 2004 Aug 26;351(9):902-10. Resumo
7. Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739. Resumo
8. Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope. 2003 Jul;113(7):1199-205. Resumo
9. Taylor A. Sinusitis. Pediatr Rev. 2006 Oct;27(10):395-7. Resumo
10. Fireman P. Diagnosis of sinusitis in children: emphasis on the history and physical examination. J Allergy Clin Immunol. 1992 Sep;90(3 Pt 2):433-6. Resumo
11. Brook I. Microbiology and antimicrobial management of sinusitis. J Laryngol Otol. 2005 Apr;119(4):251-8. Resumo
12. Jenkins SG, Farrell DJ, Patel M, et al. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J Infect. 2005 Dec;51(5):355-63. Resumo
13. Martinez KA, Rood M, Rothberg MB. Coding bias in respiratory tract infections may obscure inappropriate antibiotic use. J Gen Intern Med. 2019 Jun;34(6):806-8.Texto completo Resumo
14. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020 Oct;146(4):721-67.Texto completo Resumo
15. Eloy P, Poirrier AL, De Dorlodot C, et al. Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management. Curr Allergy Asthma Rep. 2011 Apr;11(2):146-62. Resumo
16. DeGeorge KC, Ring DJ, Dalrymple SN. Treatment of the common cold. Am Fam Physician. 2019 Sep 1;100(5):281-9.Texto completo Resumo
17. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003 Sep;129(3 Suppl):S1-32. Resumo
18. Ebell MH, McKay B, Guilbault R, et al. Diagnosis of acute rhinosinusitis in primary care: a systematic review of test accuracy. Br J Gen Pract. 2016 Aug 1;66(650):e612-32.Texto completo Resumo
19. Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet. 2008 Mar 15;371(9616):908-14. Resumo
20. Dubin MG, Ebert CS, Coffey CS, et al. Concordance of middle meatal swab and maxillary sinus aspirate in acute and chronic sinusitis: a meta-analysis. Am J Rhinol. 2005 Sep-Oct;19(5):462-70. Resumo
21. Frerichs N, Brateanu A. Rhinosinusitis and the role of imaging. Cleve Clin J Med. 2020 Jul 31;87(8):485-92.Texto completo Resumo
22. American College of Radiology. ACR appropriateness criteria: sinonasal disease. 2021 [internet publication]Texto completo
23. Gendo K. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004 Feb 17;140(4):278-89. Resumo
24. Meltzer EO, Hamilos DL, Hadley JA, et al; Rhinosinusitis Initiative. Rhinosinusitis: developing guidance for clinical trials. Otolaryngol Head Neck Surg. 2006 Nov;135(5 Suppl):S31-80. Resumo
25. Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464.Texto completo Resumo
26. Silberstein SD, Holland S, Freitag F, et al; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Neurology. 2012 Apr 24;78(17):1337-45.Texto completo Resumo
27. Aring AM, Chan MM. Current concepts in adult acute rhinosinusitis. Am Fam Physician. 2016 Jul 15;94(2):97-105.Texto completo Resumo
28. US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Apr 2017 [internet publication].Texto completo
29. Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Jun 2013 [internet publication].Texto completo
30. European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. Jun 2013 [internet publication].Texto completo
31. Shaikh N, Wald ER. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Database Syst Rev. 2014 Oct 27;(10):CD007909.Texto completo Resumo
32. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005 Dec;116(6):1289-95.Texto completo Resumo
33. Hayward G, Heneghan C, Perera R, et al. Intranasal corticosteroids in management of acute sinusitis: a systematic review and meta-analysis. Ann Fam Med. 2012 May-Jun;10(3):241-9.Texto completo Resumo
34. Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013 Dec 2;(12):CD005149.Texto completo Resumo
35. AlBalawi ZH, Othman SS, Alfaleh K. Intranasal ipratropium bromide for the common cold. Cochrane Database Syst Rev. 2013 Jun 19;(6):CD008231.Texto completo Resumo
36. King D, Mitchell B, Williams CP, et al. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015 Apr 20;(4):CD006821.Texto completo Resumo
37. Lemiengre MB, van Driel ML, Merenstein D, et al. Antibiotics for acute rhinosinusitis in adults. Cochrane Database Syst Rev. 2018 Sep 10;(9):CD006089.Texto completo Resumo
38. Smith MJ. Evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: a systematic review. Pediatrics. 2013 Jul;132(1):e284-96.Texto completo Resumo
39. Guarch Ibáñez B, Buñuel Álvarez JC, López Bermejo A, et al. The role of antibiotics in acute sinusitis: a systematic review and meta-analysis [in Spanish]. An Pediatr (Barc). 2011 Mar;74(3):154-60. Resumo
40. Falagas ME, Giannopoulou KP, Vardakas KZ, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis. 2008 Sep;8(9):543-52. Resumo
41. Garbutt JM, Banister C, Spitznagel E, et al. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA. 2012 Feb 15;307(7):685-92. Resumo
42. Harris AM, Hicks LA, Qaseem A; High Value Care Task Force of the ACP and the CDC. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016 Mar 15;164(6):425-34.Texto completo Resumo
43. Babela R, Jarcuska P, Uraz V, et al. Decision and cost analysis of empirical antibiotic therapy of acute sinusitis in the era of increasing antimicrobial resistance: do we have an additional tool for antibiotic policy decisions? Neuro Endocrinol Lett. 2017 Nov;38(suppl1):9-26. Resumo
44. Rosenfeld RM. Clinical Practice. Acute sinusitis in adults. N Engl J Med. 2016 Sep 8;375(10):962-70. Resumo
45. Anon JB, Ferguson B, Twynholm M, et al. Pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains. Ear Nose Throat J. 2006 Aug;85(8):500, 502, 504. Resumo
46. National Institute for Health and Care Excellence. Sinusitis (acute): antimicrobial prescribing. Oct 2017 [internet publication].Texto completo
47. Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol. 2014 May;112(5):404-12. Resumo
48. Gaillard T, Briolant S, Madamet M, et al. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J. 2017 Apr 13;16(1):148.Texto completo Resumo
49. US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. Jul 2016 [internet publication].Texto completo
50. Adefurin A, Sammons H, Jacqz-Aigrain E, et al. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child. 2011 Sep;96(9):874-80.Texto completo Resumo
51. European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. Mar 2019 [internet publication].Texto completo
52. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. Mar 2019 [internet publication].Texto completo
53. US Food and Drug Administration. FDA drug safety communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Jul 2016 [internet publication].Texto completo
54. US Food and Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].Texto completo
55. US Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Jul 2018 [internet publication].Texto completo
56. Harrison CJ, Woods C, Stout G, et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009 Mar;63(3):511-9.Texto completo Resumo
57. Palms DL, Hicks LA, Bartoces M, et al. First-line antibiotic selection in outpatient settings. Antimicrob Agents Chemother. 2019 Nov;63(11):e01060-19.Texto completo Resumo
58. Ryan MA, Leu GR, Boss EF, et al. Adherence to American Academy of Otolaryngology-Head and Neck Surgery clinical practice guidelines: a systematic review. Otolaryngol Head Neck Surg. 2020 Oct;163(4):626-44. Resumo
59. McCoul ED. Assessment of pharmacologic ingredients in common over-the-counter sinonasal medications. JAMA Otolaryngol Head Neck Surg. 2020 Sep 1;146(9):810-5.Texto completo Resumo
60. Abuelgasim H, Albury C, Lee J. Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis. BMJ Evid Based Med. 2021 Apr;26(2):57-64. Resumo
61. Ahmed Y, Delaney S, Markarian A. Successful isavuconazole therapy in a patient with acute invasive fungal rhinosinusitis and acquired immune deficiency syndrome. Am J Otolaryngol. 2015 Dec 9;37(2):152-5. Resumo
62. Seresirikachorn K, Khattiyawittayakun L, Chitsuthipakorn W, et al. Antihistamines for treating rhinosinusitis: systematic review and meta-analysis of randomised controlled studies. J Laryngol Otol. 2017 Sep 13;132(2):105-10. Resumo
63. Ciofalo A, de Vincentiis M, Zambetti G, et al. Olfactory dysfunction in acute rhinosinusitis: intranasal sodium hyaluronate as adjuvant treatment. Eur Arch Otorhinolaryngol. 2016 Aug 27;274(2):803-8. Resumo
64. Cushen R, Francis NA. Antibiotic use and serious complications following acute otitis media and acute sinusitis: a retrospective cohort study. Br J Gen Pract. 2020 Apr;70(693):e255-63.Texto completo Resumo
65. Han JK, Kerschner JE. Streptococcus milleri: an organism for head and neck infections and abscess. Arch Otolaryngol Head Neck Surg. 2001 Jun;127(6):650-4.Texto completo Resumo
66. Carr TF. Complications of sinusitis. Am J Rhinol Allergy. 2016 Jul;30(4):241-5. Resumo
67. Mameli C, Genoni T, Madia C, et al. Brain abscess in pediatric age: a review. Childs Nerv Syst. 2019 Jul;35(7):1117-1128. Resumo
68. Ziegler A, Patadia M, Stankiewicz J. Neurological Complications of Acute and Chronic Sinusitis. Curr Neurol Neurosci Rep. 2018 Feb 5;18(2):5. Resumo
69. Adil EA, Muir ME, Kawai K, et al. Pediatric subperiosteal abscess secondary to acute sinusitis: a systematic review and meta-analysis. Laryngoscope. 2020 Dec;130(12):2906-12. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal